Back to Search
Start Over
A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling.
- Source :
-
Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2014 Aug; Vol. 173 (8), pp. 2174-88. Date of Electronic Publication: 2014 Jun 27. - Publication Year :
- 2014
-
Abstract
- Malaria is one of the most infectious diseases in the world. Plasmodium vivax, the pathogen causing endemic malaria in humans worldwide, is responsible for extensive disease morbidity. Due to the emergence of resistance to common anti-malarial drugs, there is a continuous need to develop a new class of drugs for this pathogen. P. vivax cysteine protease, also known as vivapain-2, plays an important role in haemoglobin hydrolysis and is considered essential for the survival of the parasite. The three-dimensional (3D) structure of vivapain-2 is not predicted experimentally, so its structure is modelled by using comparative modelling approach and further validated by Qualitative Model Energy Analysis (QMEAN) and RAMPAGE tools. The potential binding site of selected vivapain-2 structure has been detected by grid-based function prediction method. Drug targets and their respective drugs similar to vivapain-2 have been identified using three publicly available databases: STITCH 3.1, DrugBank and Therapeutic Target Database (TTD). The second approach of this work focuses on docking study of selected drug E-64 against vivapain-2 protein. Docking reveals crucial information about key residues (Asn281, Cys283, Val396 and Asp398) that are responsible for holding the ligand in the active site. The similarity-search criterion is used for the preparation of our in-house database of drugs, obtained from filtering the drugs from the DrugBank database. A five-point 3D pharmacophore model is generated for the docked complex of vivapain-2 with E-64. This study of 3D pharmacophore-based virtual screening results in identifying three new drugs, amongst which one is approved and the other two are experimentally proved. The ADMET properties of these drugs are found to be in the desired range. These drugs with novel scaffolds may act as potent drugs for treating malaria caused by P. vivax.
- Subjects :
- Amino Acid Sequence
Antimalarials metabolism
Binding Sites
Catalytic Domain
Cysteine Proteases genetics
Cysteine Proteases metabolism
Databases, Factual
Drug Evaluation, Preclinical instrumentation
Humans
Malaria, Vivax parasitology
Models, Molecular
Molecular Sequence Data
Plasmodium vivax chemistry
Plasmodium vivax drug effects
Plasmodium vivax genetics
Protozoan Proteins antagonists & inhibitors
Protozoan Proteins genetics
Protozoan Proteins metabolism
Sequence Alignment
Antimalarials chemistry
Antimalarials pharmacology
Cysteine Proteases chemistry
Cysteine Proteinase Inhibitors chemistry
Cysteine Proteinase Inhibitors pharmacology
Drug Evaluation, Preclinical methods
Plasmodium vivax enzymology
Protozoan Proteins chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1559-0291
- Volume :
- 173
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Applied biochemistry and biotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 24970047
- Full Text :
- https://doi.org/10.1007/s12010-014-1023-y